PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:01 AM ET

Sponsor Check › Person

JN
No photo found yet (own website and image search run after this page is viewed)

James Nadauld

Named as an officer, director or promoter on SEC Form D filings · PA, UT · Mar 13, 2020 → Jun 22, 2026

7deals (issuers)
$160.4Mreported sold
137investors
9Form D filings
2020–2026years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:45 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

James Nadauld is listed as an executive officer, director, and promoter on 9 SEC Form D filings by 7 issuers between Jul 2015 and Jun 2026. Largest by amount reported sold: Cimarron Healthcare Capital Fund II, LP (Salt Lake City, UT — pooled investment fund — 2021–2023; $118.7M reported sold to 114 investors), CAMSO Holdings, LLC (Salt Lake City, UT — industry reported as "Other" — 2021; $29.2M reported sold to 5 investors), Olympus Ascent Investors, LLC (Salt Lake City, UT — other health care — 2020; $11.5M reported sold to 17 investors), Cimarron Healthcare Investments II, LP (Bala Cynwyd, PA — pooled investment fund — 2015; $1M reported sold to 1 investors), AMPS Ardlussa SPV, LP (Salt Lake City, UT — pooled investment fund — 2026) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer, director, and promoter, over about 11 years. Across those companies the filings report $160.4M sold in total.

Listed alongside Alton Matthew Stoker (1 shared filing), Clay Andrus (1 shared filing), Jason VandenAkker (1 shared filing), Nicholas Smith (1 shared filing), Olympus Ascent GP, LLC (1 shared filing, management entity) and 1 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.

All 7 issuers belong to the sponsor group Cimarron Healthcare (7 issuers, $160.4M reported sold, 2015–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Cimarron Healthcare has 7 companies on file and $160.4M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name listed in Key records below.

What this means 1 record came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 9 public filings for James Nadauld and found 7 differences, 1 worth asking the sponsor about: Form D filed 93 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for James Nadauld has not run yet — it is joining a line of 4,575 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 open

Viking Insurance Company of Wisconsin v. Nadauld open
District Court, D. Oregon · No. 1:26-cv-00084 · Filed Jan 15, 2026
Role of Nadauld: Defendant · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (5 people in Form D filings, 1 federal dockets); surname only in the caption; court in OR (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:45 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched James Nadauld..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:45 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

7 differences found between the filings for James Nadauld — 1 worth asking about (compared 9 filings on Oct 24, 2026)

Worth asking · Oct 18, 2021 – Jan 19, 2022

Form D filed 93 days after the first sale — Cimarron Healthcare Capital Fund II, LP

The filing says the first sale was Oct 18, 2021. The Form D was filed Jan 19, 2022 — 93 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 78 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jan 31, 2020 – Mar 13, 2020

Form D filed 42 days after the first sale — Olympus Ascent Investors, LLC

The filing says the first sale was Jan 31, 2020. The Form D was filed Mar 13, 2020 — 42 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 27 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Jun 19, 2015 – Jul 6, 2015

Form D filed 17 days after the first sale — Cimarron Healthcare Investments II, LP

The filing says the first sale was Jun 19, 2015. The Form D was filed Jul 6, 2015 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Oct 18, 2021 – Feb 6, 2023

No amendment in the last 12 months on an offering that may still be open — Cimarron Healthcare Capital Fund II, LP (latest filing Feb 6, 2023)

The latest filing for this offering is dated Feb 6, 2023 (first sale Oct 18, 2021). It reports $118,670,000 sold of an indefinite amount offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jun 19, 2015 – Jul 6, 2015

No amendment in the last 12 months on an offering that may still be open — Cimarron Healthcare Investments II, LP (latest filing Jul 6, 2015)

The latest filing for this offering is dated Jul 6, 2015 (first sale Jun 19, 2015). It reports $1,000,000 sold of $2,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jan 6, 2010 – Aug 23, 2019

Same name, different state: "James Nadauld" (CA) is a separate record

This page covers filings where the address state is PA or UT. A separate record, "James Nadauld" with address state CA, is listed on 5 filings — most recently by Infusion Investors, LLC (Aug 23, 2019). The two records do not overlap in time: this page runs Mar 13, 2020 to Jun 22, 2026; the other runs Jan 6, 2010 to Aug 23, 2019.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Jul 6, 2015 – Jun 22, 2026

James Nadauld is listed with 2 different address states: PA, UT

PA on 1 filing (Jul 6, 2015); UT on 8 filings (Mar 13, 2020 to Jun 22, 2026).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

3 of 8 offerings report sales commissions totalling $8,130,000; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 22, 2026 D
AMPS Ardlussa SPV, LP
File 021-588041
$0$0$0None listed on this filingEDGAR ↗
Apr 21, 2023 D
PV365 Co-Invest, LP
File 021-479736
$0$0$0None listed on this filingEDGAR ↗
Feb 6, 2023 D/A
Cimarron Healthcare Capital Fund II, LP
File 021-429910
$3,500,000 (est.)$0$0Houlihan Lokey Capital, Inc. BrokerCheck CRD 17708 ↗EDGAR ↗
Mar 19, 2021 D
Cimarron Continuation Fund, LP
File 021-392807
$1,130,000 (est.)$0$0Houlihan Lokey Capital, Inc BrokerCheck CRD 17708 ↗EDGAR ↗
Feb 17, 2021 D
CAMSO Holdings, LLC
File 021-389696
$0$0$0None listed on this filingEDGAR ↗
Jan 25, 2021 D
Cimarron Healthcare Capital Fund II, LP
File 021-387187
$3,500,000 (est.)$0$0Houlihan Lokey Capital, Inc. BrokerCheck CRD 17708 ↗EDGAR ↗
Mar 13, 2020 D
Olympus Ascent Investors, LLC
File 021-362819
$0$0$0None listed on this filingEDGAR ↗
Jul 6, 2015 D
Cimarron Healthcare Investments II, LP
File 021-243096
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named James Nadauld on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pooled Investment Fund · group: Cimarron Healthcare

AMPS Ardlussa SPV, LP

Salt Lake City, UT · Jun 22, 2026
  • Jun 22, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Manager of the General Partner of the Issuer) EDGAR ↗

No sales reported yet as of the latest filing. James is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Cimarron Healthcare

PV365 Co-Invest, LP

Salt Lake City, UT · Apr 21, 2023
  • Apr 21, 2023 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Executive Officer of the General Partner of Issuer) EDGAR ↗

No sales reported yet as of the latest filing. James is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Cimarron Healthcare

Cimarron Healthcare Capital Fund II, LP

Salt Lake City, UT · Jan 25, 2021 → Feb 6, 2023 · 3 filings
  • Feb 6, 2023 · D/A · $118,670,000 sold of Indefinite · 114 investors · min. No minimum reported · role: Executive Officer (Executive officer of the General Partner of the Issuers) EDGAR ↗
  • Jan 19, 2022 · D · $104,380,000 sold of Indefinite · 86 investors · min. No minimum reported · role: Executive Officer (Executive officer of the General Partner of the Issuers) EDGAR ↗
  • Jan 25, 2021 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Executive officer of the General Partner of the Issuers) EDGAR ↗

Raised $118.7M from 114 investors as of the latest filing. James is listed as executive officer on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Cimarron Healthcare

Cimarron Continuation Fund, LP

Salt Lake City, UT · Mar 19, 2021
  • Mar 19, 2021 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Member of the Managing Member of the General Partner of Issuer) EDGAR ↗

No sales reported yet as of the latest filing. James is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other · group: Cimarron Healthcare

CAMSO Holdings, LLC

Salt Lake City, UT · Feb 17, 2021
  • Feb 17, 2021 · D · $29,216,162 sold of $29,216,162 · 5 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $29.2M from 5 investors (100% of the $29.2M target) as of the latest filing. James is listed as executive officer, director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Cimarron Healthcare

Olympus Ascent Investors, LLC

Salt Lake City, UT · Mar 13, 2020
  • Mar 13, 2020 · D · $11,495,832 sold of $11,495,832 · 17 investors · min. $63,750 · role: Executive Officer, Promoter EDGAR ↗

Raised $11.5M from 17 investors (100% of the $11.5M target) as of the latest filing. James is listed as executive officer, promoter.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Cimarron Healthcare

Cimarron Healthcare Investments II, LP

Bala Cynwyd, PA · Jul 6, 2015
  • Jul 6, 2015 · D · $1,000,000 sold of $2,000,000 · 1 investors · min. No minimum reported · role: Executive Officer (Managing member of the general partner of the Issuer) EDGAR ↗

Raised $1M from 1 investor (50% of the $2M target) as of the latest filing. James is listed as executive officer.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • James Nadauld — CA, 4 issuers, Jan 6, 2010 → Aug 23, 2019 · no shared issuer

People around James 6

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity

Olympus Ascent GP, LLC

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Nadauld. Their page shows their other deals.

CA
No photo found yet (own website and image search run after this page is viewed)
Person

Clay Andrus

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as James Nadauld. Their page shows their other deals.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Smith

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Nadauld. Their page shows their other deals.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Jason VandenAkker

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Nadauld. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Tammy Le

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Nadauld. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Alton Matthew Stoker

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as James Nadauld. Their page shows their other deals.

The team behind the deals

Sponsor group

Cimarron Healthcare

7 issuers · 9 filings · $160.4M reported sold · 2015–2026

One team, 7 deal companies. James Nadauld is listed on 7 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name James Nadauld.

Same business address

27 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 7 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to James Nadauld by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers James Nadauld is listed on: none on file. No website or social profile named in CAMSO Holdings, LLC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #199,667 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Salt Lake City, UT). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when James Nadauld appears on a new Form D, or when a court case or SEC action is matched to them. See plans →